Sage Journals: Discover world-class research

Open access

Research article

First published 2022

Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD

Yiwen Gong, Yinghua Lv, Hongxia Liu [...]

Therapeutic Advances in Respiratory Disease

Free access

Review article

First published 2011-10

Profiling the bronchodilator effects of the novel ultra-long-acting β 2 -agonist indacaterol against established treatments in chronic obstructive pulmonary disease

Claus Vogelmeier, Helgo Magnussen, Craig LaForce [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2013-7

Aclidinium Bromide: An Alternative Long-Acting Inhaled Anticholinergic in the Management of Chronic Obstructive Pulmonary Disease

J Andrew Woods, Kimberly L Nealy, Robert W Barrons

Annals of Pharmacotherapy

Free access

Research article

First published 2014-12

Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized,double-blind clinical trials

François Maltais, Sally Singh, Alison C. Donald [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2020

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials

Sanjay Sethi, James F. Donohue, Gary T. Ferguson [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2020-04

Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma

Dik Ng, Edward M. Kerwin, Martha V. White [...]

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Free access

Review article

First published 2012-12

The potential for aclidinium bromide,a new anticholinergic,in the management of chronic obstructive pulmonary disease

François Maltais, Julie Milot

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2021

Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial

Klaus F. Rabe, Fernando J. Martinez, Dave Singh [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2016-4

Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis

Max Schlueter, N Gonzalez-Rojas, Michael Baldwin [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Meeting report

First published 2019-10

Tolerability of Revefenacin and Formoterol Via Nebulization in Patients With Moderate to Very Severe COPD: A Subgroup Analysis of a Phase 3 Trial

Thomas M. Siler, Edmund J. Moran, Chris N. Barnes [...]

Respiratory Care

Search results